Go back

Coronavirus developments at a glance—22 May

A message on mental health from the UK science minister, $1bn for vaccines, and more

Ministerial message: In an exclusive opinion piece for Research Professional News, UK science minister Amanda Solloway says the mental health impacts of Covid-19 are not being ignored.


AstraZeneca has received more than $1 billion from the US government to support the development and production of a Covid-19 vaccine at the University of Oxford.

The chair of the House of Commons Science and Technology Committee has criticised the “opacity” of Public Health England leaders on their Covid-19 testing strategy.

The National Institute for Health Research has set out plans to restart research that has been paused due to Covid-19, but it said that every paused study should undergo a check of its viability before restarting

Dutch R&D spending following the coronavirus pandemic should be channelled towards research that leads to economic impact within four years, according to a study.

The coronavirus pandemic is causing increased job insecurity for Australia’s female scientific researchers, with 6.3 per cent losing their jobs from mid-March to mid-April, a report commissioned by the federal government has said.